文献速递生殖医学

经卵胞浆内单精子注射受孕的年轻男性的代谢健康

The metabolic health of young men conceived using intracytoplasmic sperm injection.
PubMed 文献 · Hum Reprod · 2022-01-01

该队列研究比较了121名经卵胞浆内单精子注射(ICSI)受孕男性、74名经体外受精(IVF)受孕男性和688名自然受孕(SC)对照的代谢健康。调整协变量后,与SC对照相比,ICSI受孕男性舒张压更高、空腹血糖更低、空腹胰岛素更高、HOMA-IR更高、高密度脂蛋白胆固醇更高、超敏C反应蛋白更低;与IVF受孕 singleton 男性相比,仅血糖存在差异。

要点

  • 与自然受孕对照相比,ICSI受孕男性舒张压更高(β 4.9,95% CI 1.1-8.7)。
  • 与自然受孕对照相比,ICSI受孕男性HOMA-IR更高(比值 1.9,95% CI 1.4-2.6)。
  • 与IVF受孕 singleton 男性相比,ICSI受孕 singleton 男性仅血糖存在差异(β -0.4,95% CI -0.7至-0.1)。

核心结论

  • 与自然受孕对照相比,ICSI受孕男性在部分代谢参数上存在差异,包括舒张压和HOMA-IR更高;ICSI与IVF受孕 singleton 男性的代谢参数更为接近。
  • 这些观察需要在更大规模的研究中确认,并需进一步明确健康差异是否与父母特征和/或ICSI操作相关因素有关。

研究设计与样本

  • 队列研究,比较ICSI受孕男性与来自既往队列的IVF受孕和自然受孕对照的代谢健康。
  • 纳入121名ICSI受孕男性(含100名 singleton)、74名IVF受孕对照(均为 singleton)和688名自然受孕对照(含662名 singleton)。
  • 采用多变量线性回归分析,调整包括年龄和教育水平在内的多种协变量。

主要发现

  • 调整协变量后,与688名自然受孕对照相比,121名ICSI受孕男性舒张压更高(β 4.9,95% CI 1.1-8.7)、空腹血糖更低(β -0.7,95% CI -0.9至-0.5)、空腹胰岛素更高(比值 2.2,95% CI 1.6-3.0)、HOMA-IR更高(比值 1.9,95% CI 1.4-2.6)、高密度脂蛋白胆固醇更高(β 0.2,95% CI 0.07-0.3)、超敏C反应蛋白更低(比值 0.4,95% CI 0.2-0.7)。
  • 与74名IVF受孕 singleton 男性相比,ICSI受孕 singleton 男性仅血糖存在差异(β -0.4,95% CI -0.7至-0.1)。
  • 未观察到父源不孕亚组间的差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 本研究中ICSI受孕男性的招募率低,可能存在招募偏倚。
  • ICSI受孕男性、IVF受孕男性和自然受孕对照来自不同队列,出生年份和地理位置不同。
  • 研究组和对照的评估非同期进行,且部分结局(血压、胰岛素、血糖、血脂和超敏C反应蛋白)的测量方法不同。
  • 这些观察需要在更大规模的研究中确认,并需进一步明确健康差异是否与父母特征和/或ICSI操作相关因素有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the metabolic health of men conceived using ICSI different to that of IVF and spontaneously conceived (SC) men? SUMMARY ANSWER: ICSI-conceived men aged 18-24 years, compared with SC controls, showed differences in some metabolic parameters including higher resting diastolic blood pressure (BP) and homeostasis model assessment for insulin resistance (HOMA-IR) scores, although the metabolic parameters of ICSI- and IVF-conceived singleton men were more comparable. WHAT IS KNOWN ALREADY: Some studies suggest that IVF-conceived offspring may have poorer cardiovascular and metabolic profiles than SC children. Few studies have examined the metabolic health of ICSI-conceived offspring. STUDY DESIGN, SIZE, DURATION: This cohort study compared the metabolic health of ICSI-conceived men to IVF-conceived and SC controls who were derived from prior cohorts. Participants included 121 ICSI-conceived men (including 100 singletons), 74 IVF-conceived controls (all singletons) and 688 SC controls (including 662 singletons). PARTICIPANTS/MATERIALS, SETTING, METHODS: Resting systolic and diastolic BP (measured using an automated sphygmomanometer), height, weight, BMI, body surface area and fasting serum metabolic markers including fasting insulin, glucose, total cholesterol, high-density lipoprotein cholesterol (HDLC), low-density lipoprotein cholesterol, triglycerides, highly sensitive C-reactive protein (hsCRP) and HOMA-IR were compared between groups. Data were analysed using multivariable linear regression adjusted for various covariates including age and education level. MAIN RESULTS AND THE ROLE OF CHANCE: After adjusting for covariates, compared to 688 SC controls, 121 ICSI-conceived men had higher diastolic BP (β 4.9, 95% CI 1.1-8.7), lower fasting glucose (β -0.7, 95% CI -0.9 to -0.5), higher fasting insulin (ratio 2.2, 95% CI 1.6-3.0), higher HOMA-IR (ratio 1.9, 95% CI 1.4-2.6), higher HDLC (β 0.2, 95% CI 0.07-0.3) and lower hsCRP (ratio 0.4, 95% CI 0.2-0.7) levels. Compared to 74 IVF-conceived singletons, only glucose differed in the ICSI-conceived singleton men (β -0.4, 95% CI -0.7 to -0.1). No differences were seen in the paternal infertility subgroups. LIMITATIONS, REASONS FOR CAUTION: The recruitment rate of ICSI-conceived men in this study was low and potential for recruitment bias exists. The ICSI-conceived men, the IVF-conceived men and SC controls were from different cohorts with different birth years and different geographical locations. Assessment of study groups and controls was not contemporaneous, and the measurements differed for some outcomes (BP, insulin, glucose, lipids and hsCRP). WIDER IMPLICATIONS OF THE FINDINGS: These observations require confirmation in a larger study with a focus on potential mechanisms. Further efforts to identify whether health differences are due to parental characteristics and/or factors related to the ICSI procedure are also necessary. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by an Australian National Health and Medical Research Council Partnership Grant (NHMRC APP1140706) and was partially funded by the Monash IVF Research and Education Foundation. S.R.C. was supported through an Australian Government Research Training Program Scholarship. R.J.H. is supported by an NHMRC project grant (634457), and J.H. and R.I.M. have been supported by the NHMRC as Senior and Principal Research Fellows respectively (J.H. fellowship number: 1021252; R.I.M. fellowship number: 1022327). L.R. is a minority shareholder and the Group Medical Director for Monash IVF Group, and reports personal fees from Monash IVF Group and Ferring Australia, honoraria from Ferring Australia and travel fees from Merck Serono and MSD and Guerbet; R.J.H. is the Medical Director of Fertility Specialists of Western Australia and has equity in Western IVF; R.I.M. is a consultant for and shareholder of Monash IVF Group and S.R.C. reports personal fees from Besins Healthcare and nonfinancial support from Merck outside of the submitted work. The remaining authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Catford SR, Halliday J, Lewis S, et al. The metabolic health of young men conceived using intracytoplasmic sperm injection. Hum Reprod. 2022. PMID: 36166702. doi:10.1093/humrep/deac212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。